Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 8, keine Gesamtzahl für „Table“
Suchtreffer
Begriffe & Kennungen
Besponsa · 4.8 · Table 5. Adverse reactions reported in adult patients with relapsed or refractory B-cell precursor ALL who rec
Eintrag öffnenBesponsa · 4.8 · Table 6 shows the adverse reactions reported in paediatric patients with relapsed or refractory ALL who receiv
Eintrag öffnenBesponsa · 4.8 · Table 6. Adverse reactions reported in paediatric patients with relapsed or refractory B-cell precursor ALL wh
Eintrag öffnenBesremi · 4.3 · unstable angina) or recent stroke or myocardial infarction • History or presence of autoimmune disease • Immun
Eintrag öffnenBesremi · 4.8 · Table 1. Most common adverse reactions during ropeginterferon alfa-2b treatment. CTCAE Medicinal Medicinal Dos
Eintrag öffnenBetaferon · 4.8 · Table 1: Adverse drug reactions (ADRs) based on reports from clinical trials and identified during post-market
Eintrag öffnenBetmiga · 4.8 · 9 The safety of mirabegron tablets and oral suspension was evaluated in 26 paediatric patients aged 5 to less
Eintrag öffnenBetmiga · 4.8 · The safety of mirabegron tablets and oral suspension was evaluated in 26 paediatric patients aged 5 to less th
Eintrag öffnenBetmiga · 4.8 · The safety of mirabegron tablets and oral suspension was evaluated in 86 paediatric patients aged 3 to less th
Eintrag öffnenBetmiga · 4.8 · The safety of mirabegron tablets and oral suspension was evaluated in 86 paediatric patients aged 3 to less th
Eintrag öffnenBetmiga · 4.8 · The safety of mirabegron tablets was evaluated in 8 433 adult patients with OAB, of which 5 648 received at le
Eintrag öffnenBetmiga · 4.8 · The table below reflects the adverse reactions observed with mirabegron in adults with OAB in the three 12-wee
Eintrag öffnenBetmiga · 4.8 · The table below reflects the adverse reactions observed with mirabegron in adults with OAB in the three 12-wee
Eintrag öffnenBevölkerungsdynamik
Eintrag öffnenBeyfortus · 4.8 · Table 1 presents the adverse reactions reported in 2 966 term and preterm infants (GA ≥29 weeks) who received
Eintrag öffnenBeyfortus · 4.8 · Table 1: Adverse reactions
Eintrag öffnenBeyonttra · 4.8 · Table 1: List of adverse reactions
Eintrag öffnenBeyonttra · 4.8 · The safety data reflect exposure of 421 participants with ATTR-CM to acoramidis 712 mg (as two tablets of 356
Eintrag öffnenBiktarvy · 4.5 · Table 1: Interactions between Biktarvy or its individual component(s) and other medicinal products
Eintrag öffnenBiktarvy · 4.8 · Table 2: Tabulated list of adverse reactions1
Eintrag öffnen